Stock Events

Stock Events

Mind Medicine Inc 

$15.02
851
+$0.15+1.01% Wednesday 21:00

Statistics

Day High
15.16
Day Low
14.31
52W High
18.12
52W Low
4.7
Volume
2,042,821
Avg. Volume
2,059,604
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-0.78
-0.55
-0.31
-0.08
Expected EPS
-0.496269
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-217.36MNet Income

Analyst Ratings

$33.50Average Price Target
The highest estimate is 61.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MNMD. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap606.35M
Compass Pathways operates in the psychedelic medicine space, focusing on psilocybin therapy for depression, directly competing with Mind Medicine's psychedelic-based treatments.
AtaiBeckley
ATAI
Mkt Cap1.56B
ATAI Life Sciences is a biotech company with a focus on psychedelic and non-psychedelic compounds for mental health, making it a direct competitor in the psychedelic medicine market.
GH Research
GHRS
Mkt Cap888.26M
GH Research is developing a novel therapeutic approach for mental health disorders using 5-MeO-DMT, competing in the same space as Mind Medicine's psychedelic-based treatments.
Cybin Inc
CYBN
Mkt Cap200.49M
Cybin Inc. is working on psychedelic therapeutics for psychiatric and neurological conditions, directly competing with Mind Medicine in the development of psychedelic-based treatments.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness is involved in the development of psychedelic therapies, including psilocybin and MDMA, positioning it as a competitor in the psychedelic medicine industry.
Revive Therapeutics
RVVTF
Mkt Cap4.68M
Revive Therapeutics is exploring the use of psychedelics for the treatment of mental illness and addiction, competing in the same therapeutic space as Mind Medicine.
TripAdvisor
TRIP
Mkt Cap1.87B
Red Light Holland is focused on the production, growth, and sale of a premium brand of magic truffles, entering the broader market of psychedelic substances that Mind Medicine is also targeting.
Noveris Health Sciences
MYCOF
Mkt Cap14.59M
Mydecine Innovations Group is a biotech company focusing on the development of psychedelic therapies, making it a competitor in the emerging field of psychedelic medicine.

About

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Robert Barrow
Employees
74
Country
CA
ISIN
CA60255C8850

Listings

F
DE
MMQ0.F
XNAS
US
DFTX
XNAS
US
MNMD
BOATS
BOATS
MNMD.BOATS

0 Comments

Share your thoughts

FAQ

What is Mind Medicine Inc stock price today?▼
The current price of MNMD is $15.02 USD — it has increased by +1.01% in the past 24 hours. Watch Mind Medicine Inc stock price performance more closely on the chart.
What is Mind Medicine Inc stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mind Medicine Inc stocks are traded under the ticker MNMD.
Is Mind Medicine Inc stock price growing?▼
MNMD stock has risen by +0% compared to the previous week, the month change is a +10.12% rise, over the last year Mind Medicine Inc has showed a +103.8% increase.
When is the next Mind Medicine Inc earnings date?▼
Mind Medicine Inc is going to release the next earnings report on March 05, 2026.
What were Mind Medicine Inc earnings last quarter?▼
MNMD earnings for the last quarter are -0.78 USD per share, whereas the estimation was -0.5 USD resulting in a -55.59% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Mind Medicine Inc revenue for the last year?▼
Mind Medicine Inc revenue for the last year amounts to 0 USD.
What is Mind Medicine Inc net income for the last year?▼
MNMD net income for the last year is -217.36M USD.
How many employees does Mind Medicine Inc have?▼
As of February 03, 2026, the company has 74 employees.
In which sector is Mind Medicine Inc located?▼
Mind Medicine Inc operates in the Health Care sector.
When did Mind Medicine Inc complete a stock split?▼
The last stock split for Mind Medicine Inc was on August 29, 2022 with a ratio of 1:15.
Where is Mind Medicine Inc headquartered?▼
Mind Medicine Inc is headquartered in New York, CA.